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Summary Chromophilic renal cell carcinoma is a distinct type of human renal cancer, only recently recognised
and defined by its characteristic histomorphological aspect and cytogenetic aberrations. We are the first to
report on the establishment and cytogenetic characterisation of a panel of four permanent cell lines, i.e.
chromphi-l, -2, -3 and -4, derived from strictly defined renal cell carcinomas (RCCs) of the chromophilic type
and kept in continuous culture for up to 5 years. Immunohistochemistry revealed coexpression of vimentin and
cytokeratins in all cell lines - the cytokeratin polypeptide patterns, however, varying between the different cell
lines. By light and transmission electron microscopy, various amounts of cytoplasmatic glycogen deposition
were observed, being most pronounced in chromphi-3 and -4. The mean population doubling time ranged from
24 h (chromphi-1) to 51 h (chromphi-4). Chromphi-1 tumour cells produced slowly growing tumours in nude
mice using the subrenal capsule assay. In all cell lines, cytogenetic analysis revealed numerical chromosomal
aberrations known to be characteristic for chromophilic RCCs, i.e. loss of the Y chromosome, tri- or tetrasomy
of chromosomes 7 and 17 as well as various combinations of additional structural and numerical chromosomal
aberrations. Karyological aberrations were least pronounced in chromphi-2 and most complex in chromphi-1.
Chromosomal aberrations typically affecting the short arm of chromosome 3 in clear cell RCCs were not
observed in any of our cell lines.
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Renal cell carcinoma (RCC) is the most frequent renal
neoplasm in adults, exhibiting an extremely adverse prognosis
once the tumour has metastasised and is beyond the reach of
curative surgery (deKernion et al., 1978; Maldazys and
deKernion, 1986; Neves et al., 1988). Until recently, RCC
had been considered to be a single tumour entity, showing
variable histomorphological patterns (Mostofi, 1981). Based
on distinct cytomorphological criteria, however, Thoenes et
al. (1986) introduced a refined subclassification of human
RCCs, which can reliably be applied in histopathological
diagnosis of renal cancer. Thus, the clear cell type of RCC is
composed of tumour cells showing a highly transparent
('empty') cytoplasm owing to an abundance of glycogen and
lipid. The chromophobe type of RCC is composed of tumour
cells showing a finely reticular (not 'empty') cytoplasma and
markedly pronounced cell boundaries. The chromophilic type
of RCC makes up about 15% of all renal cell cancers
(Thoenes et al., 1986) and shows either small basophilic
tumour cells poor in cytoplasm or voluminous eosinophilic
tumour cells rich in mitochondria. In contrast to the clear cell
and chromophobe types of RCC, which perferentially exhibit
a compact growth pattern, 80% of the chromophilic RCCs
show a tubulopapillary architecture (Thoenes et al., 1986).
Therefore, the papillary type of RCC as defined by Kovacs
(1989) using cytogenetic criteria corresponds to the chromo-
philic type of RCC as previously defined by Thoenes et al.
(1986) using cytomorphological criteria. It is important to
note, however, that 20% of the chromophilic RCCs show a
non-papillary compact growth pattern, whereas clear cell
RCCs occasionally exhibit a papillary growth pattern
(Thoenes et al., 1986). Therefore, cytomorphological criteria
permit a more conclusive classification of RCCs than
structural criteria related to papillary vs non-papillary
growth.
The cytomorphological separation between clear cell,
chromophobe and chromophilic types of RCC as distinct
tumour entities has been further substantiated in the
meantime by differences in cytoskeletal composition, enzyme
synthesis and, most importantly, by recent progress in
molecular pathology demonstrating distinct genetic aberra-
tions within chromosomal and mitochondrial DNA for each
tumour type (Yoshida et al., 1986; Carrol et al., 1987; Pitz et
al., 1987; Zbar et al., 1987; Kovacs et al., 1988; Thoenes et
al., 1988; Storkel et al., 1989; Kovacs et al., 1991; van den
Berg et al., 1993; Kovacs, 1993; Latif et al., 1993; Zbar et al.,
1994).
As cell lines are irreplaceable tools for investigations into
the biological properties of RCC, a consequent subclassifica-
tion is also indispensible for RCC cell lines. Previous reports
on permanent cell lines (Hoehn and Schroeder, 1978;
Matsuda et al., 1979; Naito et al., 1982; Sytkowski et al.,
1983; Grossmann et al., 1985; Ebert et al., 1990; Anglard et
al., 1992), however, were based on the WHO classification of
RCC (Mostofi, 1981), which did not stringently separate the
different types of RCC. The papillary RCC cell line
previously described by Anglard et al. (1992) might represent
a chromophilic RCC, but has not been defined by cytogenetic
analysis and is referred to as a 'low passage' cell line without
explicit comment on its growth beyond passage 10. In our
experience, however, caution should be exercised when
considering a cell culture as 'permanent' at low passages,
because we observed cessation of growth in RCC cultures
after initial rapid outgrowth for up to 20 passages. As we are
not aware of any other report on strictly defined
chromophilic RCC cell lines, we report on the establishment
and cytogenetic characterisation of four different cell lines
originating from the chromophilic type of RCC as defined by
Thoenes et al. (1986) and kept in continuous culture for up to
5 years.
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Materials and methods
Cell culture
During the last 5 years, 42 different human renal cell
carcinomas of the chromophilic type had been available for
cultivation in vitro (34 tumours originated in male patients,
eight tumours in female patients). Tumour samples were
obtained immediately after nephrectomy and minced under
aseptic conditions with paired scissors. The resulting
mechanically macerated tissue mass was repeatedly washed
by centrifugation and finally seeded into 25 cm2 Nunclon
culture flasks (Gibco, Karlsruhe, Germany) with Dulbecco's
modified Eagle's medium (DMEM, Gibco) supplemented
with 10% fetal calf serum, penicillin and streptomycin. The
cultures were maintained at 37°C in an atmosphere with 5%
carbon dioxide. The tumour cells became adherent within 7-
10 days after seeding, forming small colonies during the next
few days. Fibroblastic contamination did not prove to be a
major problem, because fibroblasts could be removed by
selective trypsinisation during the following passages.
Only 4 out of 42 chromophilic renal cell carcinomas gave
rise to permanent cell lines, named chromphi-1, -2, -3 and -4
(Table I). These cell lines have been maintained in permanent
culture for up to 5 years and have reached passage numbers
between passages 60 (chromphi-4) and 200 (chromphi-l).
Most of our studies were performed with cells from
passage numbers 20-40, describing the cell lines at an early
in vitro stage.
Light microscopy
The original tumours were fixed in 4% formaldehyde and
embedded in Paraplast. The tumour cells cultivated in vitro
were seeded on microscope slides and fixed in situ by
immersion in 4% formaldehyde. The slides were stained
with haematoxylin-eosin and periodic acid-Schiff (PAS)
haemalum.
Scanning electron microscopy
For scanning electron microscopy, tumour cells seeded on
glass cover slips were fixed in situ by exposure to 2.5%
phosphate-buffered glutaraldehyde solution (pH 7.2) and
post-fixed in 2% osmium tetroxide solution. After dehydra-
tion in an ascending acetone series, the tumour cell
monolayer was dried by the critical point method and
sputtered with gold. Electron photomicrographs were taken
with a PSEM 510 scanning electron microscope.
Table I Data on patients' age, sex, size of original tumour, TNM
classification and tumour grade
Original tumour
Patients' age, Tumour size TNM
Cell line sex (cm) staging Grading
Chromphi-1 64 years, male 7 x 6 x 6 pT3b pNX pMX 3
Chromphi-2 63 years, male 9 x 7 x 6 pT3a pNl pMX 2
Chromphi-3 64 years, male 5x4x4 pT3a pN pMX 2
Chromphi-4 71 years, male 4x4x4 pT2 NX pMX 1
Transmission electron microscopy
For transmission electron microscopy, tumour cells seeded
on glass cover slips were fixed in situ by exposure to 2.5%
sodium cacodylate-buffered glutaraldehyde solution (0.1 M;
pH 7.4) and post-fixed in 1% sodium cacodylate-buffered
osmium tetroxide solution (0.1 M; pH 7.4) before Epon
embedding. Thin sections were contrasted with uranyl
acetate and lead citrate. Electron photomicrographs were
taken with an EM 410 Philips transmission electron
microscope.
Immunohistochemistry
For immunohistochemistry of the original tumours, either
cryostat sections from freshly obtained snap-frozen tissue
(chromphi-1) or formalin-fixed, paraffin-embedded tissue
(chromphi-2, -3, -4) was used. The cultivated tumour cells
were seeded on microscope slides, fixed in situ by exposure to
ethanol (5 min) and acetone (10 s) at -200C, then air dried
and stored at -200C. Before staining, an additional acetone
fixation (5 min at -200C) was performed, followed by air
drying. Primary antibodies (Table II) were applied to the
slides and allowed to incubate for 30 min at room
temperature in a moist chamber. The visualisation of the
primary antibodies was achieved by the indirect immunoper-
oxidase method (Thoenes et al., 1988).
Doubling time
Twenty-four replicate 25 cm2 culture flasks received inocula
of 2 x 105 cells each. Cells from four culture flasks were
harvested separately on days 3, 4, 5, 7, 9 and 11 after
inoculation. Cell counts were performed with the Neubauer
haemocytometer. The results were plotted on semilogarithmic
paper and the mean population doubling time was
determined during the exponential growth phase.
Saturation density
The maximum number of tumour cells present in confluent
25 cm2 culture flasks was determined during the plateau
phase of growth.
Tumorigenicity in nude mice
For tumorigenicity testing, tumour cells were implanted
under the renal capsule of four nude mice per cell line,
according to a procedure previously described by Fingert et
al. (1987). Briefly, 8 x 106 tumour cells were washed in
phosphate-buffered saline (PBS) by repeated centrifugation.
The cell pellet obtained was suspended in 10 ,l of PBS
supplemented with fibrinogen (20 mg ml-'). After careful
resuspension, 5 Ml of thrombin dissolved in minimum
essential medium (MEM) (20 units ml-') was added. The
clot forming after incubation at 370C for 10 min was cut in
four pieces and each piece was inserted under the renal
capsule of a 6-week-old female nude mouse. After 4 months,
the animals were sacrificed and histological examination of
kidneys and lungs was performed.
Table II List of antibodies used
Antibody Specificity Source
MAb6B10 Cytokeratin no. 4 Eurodiagnostics, Apeldoorn, Netherlands
MAbCK-7 Cytokeratin no. 7 Boehringer, Mannheim, Germany
MAbE3 Cytokeratin no. 17 Progen Biotechnics, Heidelberg, Germany
MAbKs 18.174 Cytokeratin no. 18 Progen Biotechnics
MAbKs 19.2.Z105 Cytokeratin no. 19 Progen Biotechnics
MAbIT-Ks20.5 Cytokeratin no. 20 Progen Biotechnics
MAbVIM-9 Vimentin Viramed, Martinsried, Germany
MAb, mouse monoclonal antibody.Chromophilic renal carcinoma cell lines
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Flow cytometric DNA measurement
Exponentially growing tumourcells were harvested and fixed in
70% ethanol (30 min, 4°C). Following fixation, the cells were
centrifuged, resuspended in 1 ml of phosphate-buffered saline
and incubated in 0.1 mg ml - RNAase and 40 ,ig ml-
1
propidium iodide (30 min, 37°C). The DNA content of the
tumour cells was measured with a Cytoron absolute flow
cytometer (Ortho, Heidelberg, Germany). Chicken red blood
cells were used in additional measurements as an internal
calibration standard for DNA ploidy, the DNA ofchicken red
blood cells being 35% ofthe human diploid value (Vindelov et
al., 1983). The ploidy level ofthe tumour cells was expressed as
DNA index, the DNA index of diploid human cells being 1.0.
For the analysis ofcell cycle distributions the ModFit program
(Verity, Topsham, M, USA) was used.
Chromosome analysis
Chromosome preparations were obtained from exponentially
growing cell cultures using standard cytogenetic procedures.
Each cell line was analysed at a low passage number (chromphi-
1, passage no. 6; chromphi-2, passage no. 23; chromphi-3,
passage no. 20; chromphi-4, passage no. 16) and at a high
passagenumber(passage no. 50forallcelllines). Briefly, tumour
cells treated with 0.04 jMg 1` colcemid for 0.5-7 h were
harvested, exposed to hypotonic 0.075 M potassium chloride
at 370C for 25 min and fixed in methanol/acetic acid for 1 h. G-
banding was performed applying the technique of Seabright
(1971). Cytogenetic analysis was performed with at least two
separately harvested preparations ofeachcell line and atleast 30
G-banded metaphases per cell line were karyotyped. Descrip-
tion of karyotypes was done according to ISCN (Mitelman,
1995). The composite karyotype ofeach cell line was defined as
the most consistent chromosomal presentation in multiple cells,
neglecting random losses or gains of individual chromosomes.
All marker chromosomes seen in at least three cells were
included in the karyotype.
Isolation of clonal subpopulations
Cloning procedures were performed as previously described
(Gerharz et al., 1989; Engers et al., 1994). Briefly, a single-cell
suspension of tumour cells was diluted to a concentration of 3
cells ml-', and 0.1 ml of this cell suspension was inoculated
into each well of a micro-well plate 96 (Gibco, Eggenstein,
Germany). Each well was inspected by inverted microscopy and
wells containing a single cell were marked. After incubating the
microplates in a moist atmosphere containing 5% carbon
dioxide, the developing clones were transferred to a 24-well
multidish (Gibco) and further expanded in 25 cm2 flasks. As the
cloning efficiency (=ratio between the number of clones
obtained and the number of cells seeded) was rather low,
cloning experiments were repeated with feeder cells lethally
irradiated with 10 000 rad before the inoculation ofRCC cells.
Results
Original tumours
The original tumours were typical representatives of the
chromophilic type of renal cell carcinoma as defined by
Thoenes et al. (1986). In haematoxylin and eosin-stained
sections, the tumours exhibited a tubulopapillary growth
pattern with connective tissue axes covered by simple or
stratified basophilic (tumours 1,3,4) or eosinophilic (tumour
2) epithelium (Figure 1). Tumour 1 showed markedly
enlarged nuclei with irregular outlines and prominent
nucleoli corresponding to a grade 3 malignancy. Tumours 2
and 3 exhibited only moderately enlarged nuclei, correspond-
ing to grade 2 malignancy. The nuclei of tumour 4 had
roughly the size of norlnal tubule cell nuclei, corresponding
to grade 1 malignancy. Periodic acid-shift staining revealed
no appreciable amounts of glycogen. The cytoskeletal
architecture as revealed by immunohistochemistry is sum-
marised in Table III.
Cell lines
In vitro growth properties The in vitro growth properties of
the cell lines chromophi-1, -2, -3, and -4 are summarised in
Table IV. The cell line chromphi-1 exhibited the shortest
mean population-doubling time, whereas chromphi-4 was the
cell line growing most slowly, its mean population-doubling
time exceeding 2 days. The saturation density was lowest in
chromphi-2 (1.3 x 105 cells cm-2) and highest in chromphi-4
(2 x 105 cells cm-2).
In vitro morphology As shown by scanning electron
microscopy (Figure 2), all cell lines grow strictly anchorage
dependent as monolayers. The tumour cells of all cell lines
exhibited a polygonal shape and were either tightly apposed
(chromphi-1) or separated by irregular spaces bridged by
cytoplasmic microspikes (chromphi-2, -3, and -4).
In contrast to the original tumours, PAS staining revealed
glycogen deposition in all cell lines, the amount of glycogen,
however, varying fromcell line to cell line (Figure 3a -d). Thus,
tumour cells with an intensively positive PAS staining reaction
were scattered between tumour cells without appreciable
cytoplasmatic staining in chromphi-l and -2. Chromphi-3 and
-4 exhibited extensive glycogen deposits in most tumour cells.
Transmission electron microscopy confirmed these differences
in glycogen deposition showing deposits of monoparticulate
glycogen (Figure 3e and f). Mitochondria and profiles ofrough
endoplasmatic reticulum (Figure 3g) were distributed rather
evenly throughout the cytoplasm, sometimes intermingled with
small aggregates of lipid droplets. Desmosome-like junctions
were only occasionally observed (Figure 3h).
Immunocytochemically, all cell lines uniformly showed a
cytoplasmic fibrilar staining of essentially all cells with the
antibody against vimentin (Figure 4a and b), but markedly
differed in their cytokeratin expression (Table V). Thus,
cytokeratin no. 7 was exclusively observed in chromphi-2 cells
(Figure4c) but notin the othercell lines(Figure4d). Antibodies
against cytokeratin nos. 18 (Figure 4e and f) and 19 (Figure 4g
and h) produced a positive-staining reaction in all cell lines, the
proportion ofpositive tumour cellsvarying from cell line to cell
line. In particular, chromphi-4 cells differed from the other cell
lines in thatthe tumourcells showed aremarkably faint staining
reaction for cytokeratin nos. 18 (Figure 4f) and 19 (Figure 4h).
Antibodies against cytokeratin no. 20 revealed a positive
staining in most cells of chromphi-1, but only very rarely in
tumour cells ofchromphi-2 (Figure 4i) and -3. (In the original
tumour ofchromphi-1, extensive immunohistochemical screen-
ingofmultipletissueblockshadrevealedcytokeratinno. 20only
in afew tumourcellslyingwithin small bloodvesselsadjacentto
the tumour.) No staining reaction for cytokeratin no. 20 was
observed in chromphi-4 cells (Figure 4j). On the whole,
chromphi-4 cells exhibited the lowest degree of cytokeratin
expression (Table V). The intracellular cytokeratin filament
network at chromphi-4 cells appeared poorly developed,
showing paranuclear condensations, whereas the vimentin
filament network was extended. Expression ofcytokeratin nos.
4 and 17 was not observed in any cell line.
Tumorgenicity in nude mice
The cell line chromphi-3 produced slowly growing tumours in
two out of 4 nude mice; the tumours reaching a diameter of
0.4 cm after an observation period of 4 months. Histological
examination revealed a tubulopapillary growth pattern
closely resembling the original tumour. The other cell lines
failed to produce tumours in nude mice.
DNA measurement and cell cycle analysis
By flow cytometry, one cell line (chromphi-2) showed DNA-
diploidy whereas the other cell lines proved to be DNA-0-10*_ Chromophilic renal carcinoma cell lines
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Figure 1 Morphological aspects of the original tumours of chromphi-I (a-c) and chromphi-2 (d-f). Papillary growth pattern with
stratified basophilic epithelium in chromphi-1 (a) showing intensively positive immunostaining for cytokeratin nos. 18 (b) and 19 (c).
Papillary growth pattern with simple and stratified eosinophilic epithelium in chromphi-2 (d) showing intensively positive
immunostaining for cytokeratin nos. 18 (e) and 19 (f). a, bar=80 tim; b-d, bar = 100gim; e-f, bar= 70gim.
aneuploid (Table VI). As revealed by cell cycle analysis, the
proportion of cells in the G0/G,-phase of the cell cycle ranged
from 65% (chromphi-1) to 84% (chromphi-2).
Chromosome analysis
Cytogenetic analysis revealed both random and non-random
karyotypic changes in all cell lines (Figure 5). The composite
karyotypes neglecting random losses or gains of individual
chromosomes are presented in Table VII. Near-diploid
chromosome numbers were observed in cells of chromphi-2,
whereas the other cell lines proved to by hypotriploid
(chromphi-I and -4) or near-tetraploid (chromphi-3). All
cell lines were characterised by a loss of the Y chromosome.
Polysomy 7 was observed in all cell lines and an additional
deletion 7q became evident for chromphi-4 cells. In all cell
lines, tri- or tetrasomy 17 was seen, resulting from an
unbalanced translocation of chromosome 17 to other
chromosomes in chromphi-2 and -3. Further numerical and
structural chromosomal aberrations were observed in all cell
lines.
Table III Cytoskeletal architecture of the original tumours by
immunohistochemistry (percentage of positive cells)
Cytokeratin no. (0)
Cell line Vimentin (%) 7 18 19 20
Chromphi-1 100 NE 100 100 NEa
Chromphi-2 100 70 100 70 NE
Chromphi-3 100 NE 100 80 NE
Chromphi-4 100 100 100 80 NE
aExtensive screening of multiple tissue blocks revealed cytokeratin
no.20 only in a few tumour cells lying within small blood vessels
adjacent to the tumour. NE, no expression.
Cloning experiments
The cloning efficiency of our chromophilic RCC cell lines
proved to be low and did not exceed 1% even with the use of
irradiated feeder cells. Each clonal subpopulation (chromphi-
1: six subpopulations; chromphi-2: no subpopulations;
chromphi-3: two clonal subpopulations; chromphi-4: threeChromophilic renal carcinoma cell lines
C-D Gerharz et al
clonal subpopulations) was analysed for cytokeratin expres-
sion and glycogen deposition. These studies, however, failed
to isolate clonal subpopulations with a more homogeneous
pattern of cytokeratin expression and glycogen deposition
than the corresponding parental cell lines.
Discussion
Previous reports on the establishment and characterisation of
permanent RCC cell lines (Hoehn and Schroeder, 1978;
Matsuda et al., 1979; Naito et al., 1982; Sytkowski et al.,
1983; Grossmann et al., 1985; Ebert et al., 1990; Anglard et
al., 1992) were based on the WHO classification of RCC
(Mostofi, 1981), which did not distinguish, consequently, the
chromophilic type of RCC. The papillary RCC cell line
previously described by Anglard et al. (1992) has not been
defined by chromosomal analysis and is referred to as a 'low
passage' cell line without explicit comment on its growth
beyond passage ten. As we are not aware of any other report
on strictly defined chromophilic RCC cell lines, the purpose
of the present study was to describe the cytomorphological
and cytogenetic characteristics of four newly established cell
lines derived from the chromophilic type of RCCs as defined
by Thoenes et al. (1986).
Cell line
Chromphi-1
Chromphi-2
Chromphi-3
Chromphi-4
Table IV Growth properties in vitro
Time in
permanent Mean population
culture (years) doubling time (h)
5 24
3 1/2 40
3 40
2'/2 51
Saturation
density
(cellscm=)
1.6x 105
1.3 x 105
1.9x 105
2.0x 105
We have previously shown that cell lines derived from the
clear cell and chromophobe types ofRCC maintain the typical
intermediate filament phenotype of the original tumours
(Gerharz et al., 1993; Gerharz et al., 1994; Gerharz et al.,
1995). Here, we present evidence that an analogous conserva-
tism holds true for permanent cell lines derived from the
chromophilic type of RCC. All the cell lines consistently
exhibited a coexpression of vimentin and cytokeratins, which
had been emphasised to be a characteristic feature of
chromophilic RCCs in vivo (Pitz et al., 1987). Analysis of the
cytokeratin polypeptide patterns, however, revealed pro-
nounced phenotypic heterogeneity of cytoskeletal composi-
tion. In particular, the expression ofcytokeratin nos. 7 and 19
varied markedly between the different cell lines as well as
between cells ofthe same cell line. A corresponding cytoskeletal
heterogeneity, however, had already been observed for
chromophilic RCC in vivo (Pitz et al., 1987) and may be
because of intrinsic heterogeneity between different chromo-
philic RCCs and/or phenotypic modulation by as yet unknown
microenvironmental factors. This assumption was further
supported by our cloning experiments, which failed to isolate
clonal subpopulations with a more homogeneous pattern of
cytokeratin expression than the corresponding parental cell
lines. Chromphi-4 cells were conspicuous by their compara-
tively low level of cytokeratin expression, suggesting a more
pronounced mesenchymal differentiation component. It was
also interesting to note that chromphi-1 cells exhibited a strong
expression of cytokeratin no. 20, although cytokeratin no. 20
could be demonstrated in the original tumour only after
extensive immunohistochemical screening showing a few
positive tumour cells within small blood vessels. Cytokeratin
no. 20 is preferentially expressed in gastrointestinal, biliary,
pancreatic and urothelial tumours, and has only rarely been
observed in RCC in vivo (Moll et al., 1992). As chromphi-I was
derived from a highly malignant G3 tumour and exhibited the
most pronounced karyotypic alterations, the expression of
cytokeratin no. 20 in this cell line might simply reflect random
gene activation during the process of tumour progression.
A'AN I
Figure 2 Scanning electron microscopic aspects of the cell lines. Tightly apposed tumour cells in chromphi-l (a). Loosely apposed
tumour cells with intercellular spaces bridged by cytoplasmatic microspikes in chromphi-2 (b), chromphi-3 (c) and chromphi-4 (d).
a-d, bar=20,um.
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Figure 3 Light (a-d) and transmission electron (e-h) microscopic aspects of the cell lines. Intensively positive PAS staining
(arrows) in only some tumour cells of chromphi-I (a) and -2 (b), but in most tumour cells of chromphi-3 (c) and -4 (d). Tightly
apposed tumour cells of chromphi-1 with deposits of monoparticulate glycogen (e, arrows) shown in more detail in (f). Evenly
distributed cytoplasmatic organelles such as rough endoplasmatic reticulum and mitochondria (g) as well as occasional desmosome-
like junctions (h, arrows). a-d, bar=20 im; e, bar= lIOgm; f, bar=0.5gm; g and h, bar= 1 pm.
The deposition of large amounts of glycogen is one of the
most important cytomorphological criteria for the definition
of the clear cell type of RCC (Thoenes et al., 1986; Mayer
and Bannasch, 1988). Thus, a 380- to 840-fold increase in
glycogen content was observed in clear cell RCCs when
compared with normal kidney tissue (Steinberg et al., 1992).
Nevertheless, randomly scattered tumour cells with glycogen
deposits can also be observed in chromophilic RCCs
(Thoenes et al., 1986; Hughson et al., 1993). Biochemical
analysis revealed an activation of glycolysis and reduction of
gluconeogenesis in both types of RCC, whereas an
activation of the pentose phosphate pathway was observed
exclusively in chromophilic RCCs, but not in clear cell
RCCs (Steinberg et al., 1992). Therefore, divergent
alterations of carbohydrate metabolism between the clear
cell and chromophilic types of RCC supposedly explain
differences in the extent of glycogen deposition in vivo. In
this context, however, it was surprising to note extensive
deposits of glycogen especially in chromphi-3 and chromphi-
4 cells, imparting a 'clear cell' phenotype to these tumour
cells in vitro. This observation suggests that in vitro
cultivation might have resulted in the selection of tumour
cells with a more pronounced glycogen deposition than
generally observed for chromophilic RCCs in vivo.Chromophilic renal carcinoma cell lines
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Figure 4 Immunocytochemical aspects of chromphi-2 (a,c,e,g and i) and chromphi-4 (b,d,f,h and i). Uniform intensively positive
immunostaining for vimentin (a,b) in all tumour cells. Positive immunostaining for cytokeratin no. 7 in some tumour cells of
chromphi-2 (c, arrows) as opposed to the negative staining reaction in chromphi-4 cells (d). Positive immunostaining for cytokeratin
nos. 18 (e,f) and 19 (g,h), the immunostaining being more intensive in chromphi-2 cells (e,g). Positive immunostaining for
cytokeratin no. 20 in sparsely distributed cells of chromphi-2 (i, arrows) as opposed to the negative staining reaction in chromphi-4
(j). a-j, bar=25pum.
Table V Cytoskeletal architecture of the cell lines by immunocy-
tochemistry (percentage of positive tumour cells)
Cytokeratin no. (%)
Cell line Vimentin (%) 7 18 19 20
Chromphi-I 100 NE 100 10 80
Chromphi-2 100 70 100 100 I
Chromphi-3 100 NE 100 100 1
Chromphi-4 100 NE 85 40 NE
NE, no expression.
Despite the increased glycogen deposition, all our cell lines
consistently exhibited numerical chromosomal aberrations
known to be typical for the chromophilic (papillary) type of
RCC (Kovacs, 1989; Kovacs et al., 1991; van den Berg et al.,
1993; Kovacs, 1993). All the cell lines showed gains of
chromosomes 7 and 17 combined with a loss of the Y
chromosome. Additional numerical and structural chromo-
somal aberrations were observed in various combinations in
all cell lines. None of our cell lines, however, exhibited the
loss of a specific chromosomal region at chromosome 3p,
known to be the characteristic chromosomal marker of the
clear cell type of RCC (Yoshida et al., 1986; Carrol et al.,
1987; Zbar et al., 1987; Kovacs et al., 1988). The gain of
chromosomes 7 and 17 combined with the loss of the Y
chromosome has been identified as the common denominator
of the chromophilic (papillary) renal cell carcinoma and its
Table VI DNA index and cell cycle distribution by flow cytometry
Cell cycle distribution (%)
Cell line DNA index Go/G, S GD2/M
Chromphi-I 1.4 65 34 1
Chromphi-2 1.0 78 20 2
Chromphi-3 1.6 84 15 1
Chromphi-4 1.4 75 21 4
supposed precursor lesion, the chromophilic (papillary) renal
cell adenoma (Kovacs et al., 1991; Kovacs, 1993). The
malignant transformation of chromophilic renal cell tumours
seems to be indicated by the acquisition of additional
karyotype changes, such as polysomy of chromosomes 8,
12, 16 and 20 or loss of chromosomes 14, 21 and 22. It was
interesting, therefore, to note that chromphi-2 cells exhibited
only a minimum of additional chromosomal aberrations,
including two marker chromosomes.
The specific combination of chromosomal aberrations in
chromophilic RCCs, i.e. the loss of the Y chromosome and
polysomy ofchromosomes 7, 8, 12, 16, 17 and 20, suggests that
genes located on these chromosomes are involved in the genesis
of this specific type of renal cancer. According to the two-hit
hypothesis (Knudson, 1987), the development ofcancer might
be associated with a sequence ofgenetic events resulting in the
I
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loss of both wild-type alleles of a tumour suppressor gene.
Therefore, it has been hypothesised that a tumour-suppressor
gene might be localised at the homologous regions ofthe X and
Y chromosomes (Kovacs et al., 1991; Kovacs, 1993). In this
context, it is interesting to note the strong male preponderance
ofchromophilic(papillary)renalcellcarcinoma,whichhasbeen
estimated to be as high as 8: 1 (Kovacs, 1993), and which also
was evidentin ourinvestigation. As themutational inactivation
of the putative tumour-suppressor gene at the homologous
regions ofthe X and Y chromosomes should occur at the same
frequency by chance, other factors must contribute to the
unequal sex distribution of chromophilic RCCs. A possible
explanationmight bederived from recentobservations showing
a high frequency ofchromosomal mosaicism in normal kidney
tissues obtained frompatientswithrenalcancer. Aclonallossof
the Y chromosome was observed in 21 out of31 (68%) normal
kidney probes obtained from men as opposed to clonal
monosomy X in 1 out of 14 (7%) normal kidney probes
obtained from women (Emanuel et al., 1992). Therefore,
precursor cells having only one allele ofthe putative suppressor
gene seem to be more prevalent in male kidneys than in female
kidneys, thus probably determining the male preponderance of
chromophilic (papillary) RCC (Kovacs et al., 1994).
On the other hand, the initiation of chromophilic tumour
cells could also be related to the polysomy of chromosomes
carrying mutant genes, as the amplification of mutant vs
Figure 5 Representative karyotypes of chromphi-l (a), chromphi-2 (b), chromphi-3 (c) and chromphi-4 (d).
Table VII Description of karyotypes in accordance with ISCN (1995)
Description ofkaryotype (low passage number/high passage number)
Hypotriploid: 65-67, XX,-Y, del(l)(q25-.qter)2x, der(l;?)(qlO;?),
+der(l;?)(q0;?),der(1;15)(q1O;q10)2x, - Ip, +2,
der(2)del(2)(p21 --pter)add(2)(q3?)2x, -3,add(3)(p25)2x,-4,
add(6)(q2?), +7,der(?;8)(?;q10),-9,- 11, + 12,del(12)(q15? -qter)2x,
- 13,der(13)add(13)(q10)2x, - 14,add(14)(q10)2x,add(15)(qI0),
+add(I5)(q10), + 16,- 19,-20,- 21,- 22, +mar, +mar, +mar[cp20]/65 - 67,
idem[cplO]
Near diploid: 45 - 48,X,-Y, +7, + 12, +der(l7;21)(qIO;q10),-21, +mar,
+mar[cp20]/44- 46,idem,-10,-mar,-mar[cplO]
Near tetraploid:78 84,XX,-Y,-Y,-1, + 5,-6,add(6)(q?), +7, +7,
del(l1)(q23-qter),del(11)(q22-qer), + 14, + 16,
der(14?)t(14;17)(ql2?;q21?)2x, +20,-21,-21,-21,-21,-22,-22, +mar,
+mar, +mar,[cp20]/78 81,idem,-2,-add(6)(q?),-9,-9, +20,-22[cplO]
Hypotriploid:62 66;XX,-Y,add(1)(p36), +2,del(4)(q3?--qter),
+der(4;14)(ql3;q22), +del(7)(q22-+qter),-9,
der(lO)t(8;10)(ql3?;p13?), + lO,i(l0)(q0), + 17,- 18, +20, +20,-21,
+mar, +mar,[cp20]/60- 64,idem,-i( 0)(qI 0), - 16,- 19, +20[cpI0]
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normal alleles has also been shown to affect cell proliferation
and differentiation (Klein, 1981). So far, however, the genes
actually affected by the polysomy of chromosomes 7, 8, 12,
16, 17 and 20 in chromophilic tumours remain to be defined.
In conclusion, the newly established cell lines represent a
spectrum of chromophilic RCCs defined by distinct
cytomorphological criteria and cytogenetic aberrations, not
observed in the clear cell and chromophobe types of RCC.
Therefore, these cell lines will become valuable tools for
further investigations on the genetic, molecular and biological
properties of chromophilic RCCs. Experimental studies
analysing the invasive behaviour and the response to
biological response modifiers in chromophilic RCCs are
currently in progress in our laboratory.
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